Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Propagermanium
Drug ID BADD_D01858
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01626
MeSH ID C066750
PubChem ID 83030
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 1Q2P9TO9Q7
Synonyms propagermanium | bis(carboxyethyl)germanium sesquioxide | DCEFSQD | carboxyethylgermanium sesquioxide | dicarboxyethenylgermanium sesquioxide | repagermanium | proxigermanium | dihydrogen bis(2-carboxylatoethyl)trioxodigermanate(2-) | bis(2-carboxyethyl)germanium sesquioxide | beta carboxyethylgermanium sesquioxide | 3,3'-(1,3-dioxo-1,3-digermoxanediyl)dipropionic acid | Ge 132 | Germanium-132 | Ge-132 | Arlamol Gel | 3-oxygermylpropionic acid polymer | SK 818 | SK-818
Chemical Information
Molecular Formula C6H10Ge2O7
CAS Registry Number 12758-40-6
SMILES C(C[Ge](=O)O[Ge](=O)CCC(=O)O)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Vision blurred06.02.06.007; 17.17.01.010--
VIth nerve paralysis06.05.02.009; 17.04.02.002---
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Tubulointerstitial nephritis20.05.02.002---
Musculoskeletal disorder15.03.05.025---
Brain oedema12.01.10.010; 17.07.02.003--
Quadriparesis17.01.04.012---
Left ventricular dysfunction02.04.02.011--
Acute coronary syndrome02.02.02.015; 24.04.04.011---
Cytokine release syndrome10.02.01.010--
Haemodynamic instability24.03.02.006---
Musculoskeletal stiffness15.03.05.027---
Musculoskeletal discomfort15.03.04.001---
Vascular occlusion24.04.02.015---
Affect lability19.04.01.001---
Cognitive disorder17.03.03.003; 19.21.02.001--
Nuchal rigidity15.05.04.005; 17.05.02.006---
Vasodilation procedure25.03.01.001---
Muscle relaxant therapy25.16.01.001---
Bacterial infection11.02.01.005---
Central nervous system infection11.01.03.004; 17.06.09.001---
Lymphoproliferative disorder01.13.02.001; 16.21.02.001---
Malnutrition14.03.02.004---
Mental disorder19.07.01.002---
Decreased appetite08.01.09.028; 14.03.01.005--
Ill-defined disorder08.01.03.049---
Autonomic neuropathy17.05.01.009---
Obstructive airways disorder22.03.01.011---
Psychotic disorder19.03.01.002--
The 6th Page    First    Pre   6 7    Next   Last    Total 7 Pages